Shares of Applied DNA Sciences, Inc. (APDN) are currently gaining over 30% on Friday morning after the U.S. FDA approved Emergency Use Authorization for expanded used of its COVID-19 testing kit.
APDN is currently trading at $11.56, up $2.85 or 32.72%, on the Nasdaq.
Applied DNA Sciences said FDA granted an Emergency Use Authorization amendment that both expands the installed base of PCR equipment platforms that can process the company's LineaTM COVID-19 Assay Kit and introduces automation to significantly increase the throughput of the assay by use of robotic RNA extraction.
The EUA amendment extends the RT-PCR platform authorization from the Applied Biosystems QuantStudio Dx to include Applied Biosystems' QuantStudio 5 Real-Time PCR system.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.